KRAS and neoplasm: Detecting KRAS and EGFR mutations in serum exosomes may have greater clinical significance than detecting circulating tumor DNA.[15, 16] However, research on exosomal DNA has primarily focused on surveillance of tumorigenesis and development, and the precise mechanism of action of exosomal DNA in tumor progression remains to be fully elucidated.